Amanta healthcare Limited has filed its annual regulatory disclosures under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the financial year ended March 31, 2026. The company submitted the mandatory compliance documents to both stock exchanges on April 2, 2026.

Regulatory Filing Details

The disclosures were filed under Regulation 31(4) of SEBI SAST Regulations with both BSE Limited and National Stock Exchange of India Limited. The company maintains its listing on both exchanges with specific identifiers for trading purposes.

Promoter Group Declaration

Chairman & Managing Director Bhavesh G. Patel, representing the promoter and promoter group, has made a comprehensive declaration regarding share encumbrance. The promoter group has confirmed that no encumbrance was created, directly or indirectly, on the shares or securities of Amanta Healthcare Limited during the financial year 2025-26.

This declaration ensures transparency in promoter holdings and compliance with SEBI's substantial acquisition and takeover regulations. The filing demonstrates the company's commitment to maintaining proper corporate governance standards and regulatory adherence.

Corporate Compliance

The annual disclosures were executed by key company officials to ensure proper authorization and compliance. Company Secretary & Compliance Officer Nikhita Dinodia coordinated the filing process, while promoter Bhavesh Girishbhai Patel provided the necessary declarations on behalf of the promoter group.

The company operates from its registered and corporate office located at 8th Floor, Shaligram Corporates, CJ Marg, Ambli, Ahmedabad-380058, Gujarat. These annual disclosures form part of the company's ongoing regulatory obligations as a listed entity, ensuring transparency in promoter activities and shareholding patterns for investor protection and market integrity.

Amanta Healthcare announced that its promoter and Chairman & Managing Director, Bhavesh Girishbhai Patel, has increased his stake in the company through open market purchases. The disclosure was submitted to stock exchanges on April 1, 2026, in compliance with SEBI regulations.

Transaction Details

The share acquisition was executed across two trading sessions on the National Stock Exchange (NSE). The following table summarizes the key transaction parameters:

Shareholding Changes

The open market purchases resulted in a marginal increase in Patel's ownership percentage. His shareholding position before and after the transactions is detailed below:

Regulatory Compliance

Amanta Healthcare submitted Form C under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The disclosure was filed by Company Secretary & Compliance Officer Nikhita Dinodia on behalf of the company.

The intimation to the company was made on March 31, 2026, one day after the completion of the share purchases. The company promptly communicated this information to both BSE and NSE on April 1, 2026, ensuring full regulatory compliance.

Promoter Profile

Bhavesh Girishbhai Patel serves as the Promoter, Chairman & Managing Director of Amanta Healthcare Limited. His contact details and PAN (AAYPP0537H) along with DIN (00085505) were disclosed as part of the regulatory filing. The promoter is based in Ahmedabad, Gujarat, and maintains his registered address at Saket 2, Ghelfipura, Near Samruddha Dairy, Sarkhej.